Factors affecting willingness to provide buprenorphine treatment

Julie Netherland, Michael Botsko, James E. Egan, Andrew J. Saxon, Chinazo O. Cunningham, Ruth Finkelstein, Mark N. Gourevitch, John A. Renner, Nancy Sohler, Lynn E. Sullivan, Linda Weiss, David A. Fiellin

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Buprenorphine is an effective long-term opioid agonist treatment. As the only pharmacological treatment for opioid dependence readily available in office-based settings, buprenorphine may facilitate a historic shift in addiction treatment from treatment facilities to general medical practices. Although many patients have benefited from the availability of buprenorphine in the United States, almost half of current prescribers are addiction specialists suggesting that buprenorphine treatment has not yet fully penetrated general practice settings. We examined factors affecting willingness to offer buprenorphine treatment among physicians with different levels of prescribing experience. Based on their prescribing practices, physicians were classified as experienced, novice, or as a nonprescriber and asked to assess the extent to which a list of factors impacted their prescription of buprenorphine. Several factors affected willingness to prescribe buprenorphine for all physicians: staff training; access to counseling and alternate treatment; visit time; buprenorphine availability; and pain medications concerns. Compared with other physicians, experienced prescribers were less concerned about induction logistics and access to expert consultation, clinical guidelines, and mental health services. They were more concerned with reimbursement. These data provide important insight into physician concerns about buprenorphine and have implications for practice, education, and policy change that may effectively support widespread adoption of buprenorphine.

Original languageEnglish (US)
Pages (from-to)244-251
Number of pages8
JournalJournal of Substance Abuse Treatment
Volume36
Issue number3
DOIs
StatePublished - Apr 2009

Fingerprint

Buprenorphine
Physicians
Therapeutics
General Practice
Opioid Analgesics
Mental Health Services
Prescriptions
Counseling
Referral and Consultation
Pharmacology
Guidelines
Education
Pain

Keywords

  • Buprenorphine
  • HIV
  • Opioid-related disorders
  • Physician's practice patterns
  • Willingness

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Phychiatric Mental Health
  • Medicine (miscellaneous)

Cite this

Netherland, J., Botsko, M., Egan, J. E., Saxon, A. J., Cunningham, C. O., Finkelstein, R., ... Fiellin, D. A. (2009). Factors affecting willingness to provide buprenorphine treatment. Journal of Substance Abuse Treatment, 36(3), 244-251. https://doi.org/10.1016/j.jsat.2008.06.006

Factors affecting willingness to provide buprenorphine treatment. / Netherland, Julie; Botsko, Michael; Egan, James E.; Saxon, Andrew J.; Cunningham, Chinazo O.; Finkelstein, Ruth; Gourevitch, Mark N.; Renner, John A.; Sohler, Nancy; Sullivan, Lynn E.; Weiss, Linda; Fiellin, David A.

In: Journal of Substance Abuse Treatment, Vol. 36, No. 3, 04.2009, p. 244-251.

Research output: Contribution to journalArticle

Netherland, J, Botsko, M, Egan, JE, Saxon, AJ, Cunningham, CO, Finkelstein, R, Gourevitch, MN, Renner, JA, Sohler, N, Sullivan, LE, Weiss, L & Fiellin, DA 2009, 'Factors affecting willingness to provide buprenorphine treatment', Journal of Substance Abuse Treatment, vol. 36, no. 3, pp. 244-251. https://doi.org/10.1016/j.jsat.2008.06.006
Netherland, Julie ; Botsko, Michael ; Egan, James E. ; Saxon, Andrew J. ; Cunningham, Chinazo O. ; Finkelstein, Ruth ; Gourevitch, Mark N. ; Renner, John A. ; Sohler, Nancy ; Sullivan, Lynn E. ; Weiss, Linda ; Fiellin, David A. / Factors affecting willingness to provide buprenorphine treatment. In: Journal of Substance Abuse Treatment. 2009 ; Vol. 36, No. 3. pp. 244-251.
@article{96fd33d2866548b39769db4b6205a561,
title = "Factors affecting willingness to provide buprenorphine treatment",
abstract = "Buprenorphine is an effective long-term opioid agonist treatment. As the only pharmacological treatment for opioid dependence readily available in office-based settings, buprenorphine may facilitate a historic shift in addiction treatment from treatment facilities to general medical practices. Although many patients have benefited from the availability of buprenorphine in the United States, almost half of current prescribers are addiction specialists suggesting that buprenorphine treatment has not yet fully penetrated general practice settings. We examined factors affecting willingness to offer buprenorphine treatment among physicians with different levels of prescribing experience. Based on their prescribing practices, physicians were classified as experienced, novice, or as a nonprescriber and asked to assess the extent to which a list of factors impacted their prescription of buprenorphine. Several factors affected willingness to prescribe buprenorphine for all physicians: staff training; access to counseling and alternate treatment; visit time; buprenorphine availability; and pain medications concerns. Compared with other physicians, experienced prescribers were less concerned about induction logistics and access to expert consultation, clinical guidelines, and mental health services. They were more concerned with reimbursement. These data provide important insight into physician concerns about buprenorphine and have implications for practice, education, and policy change that may effectively support widespread adoption of buprenorphine.",
keywords = "Buprenorphine, HIV, Opioid-related disorders, Physician's practice patterns, Willingness",
author = "Julie Netherland and Michael Botsko and Egan, {James E.} and Saxon, {Andrew J.} and Cunningham, {Chinazo O.} and Ruth Finkelstein and Gourevitch, {Mark N.} and Renner, {John A.} and Nancy Sohler and Sullivan, {Lynn E.} and Linda Weiss and Fiellin, {David A.}",
year = "2009",
month = "4",
doi = "10.1016/j.jsat.2008.06.006",
language = "English (US)",
volume = "36",
pages = "244--251",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Factors affecting willingness to provide buprenorphine treatment

AU - Netherland, Julie

AU - Botsko, Michael

AU - Egan, James E.

AU - Saxon, Andrew J.

AU - Cunningham, Chinazo O.

AU - Finkelstein, Ruth

AU - Gourevitch, Mark N.

AU - Renner, John A.

AU - Sohler, Nancy

AU - Sullivan, Lynn E.

AU - Weiss, Linda

AU - Fiellin, David A.

PY - 2009/4

Y1 - 2009/4

N2 - Buprenorphine is an effective long-term opioid agonist treatment. As the only pharmacological treatment for opioid dependence readily available in office-based settings, buprenorphine may facilitate a historic shift in addiction treatment from treatment facilities to general medical practices. Although many patients have benefited from the availability of buprenorphine in the United States, almost half of current prescribers are addiction specialists suggesting that buprenorphine treatment has not yet fully penetrated general practice settings. We examined factors affecting willingness to offer buprenorphine treatment among physicians with different levels of prescribing experience. Based on their prescribing practices, physicians were classified as experienced, novice, or as a nonprescriber and asked to assess the extent to which a list of factors impacted their prescription of buprenorphine. Several factors affected willingness to prescribe buprenorphine for all physicians: staff training; access to counseling and alternate treatment; visit time; buprenorphine availability; and pain medications concerns. Compared with other physicians, experienced prescribers were less concerned about induction logistics and access to expert consultation, clinical guidelines, and mental health services. They were more concerned with reimbursement. These data provide important insight into physician concerns about buprenorphine and have implications for practice, education, and policy change that may effectively support widespread adoption of buprenorphine.

AB - Buprenorphine is an effective long-term opioid agonist treatment. As the only pharmacological treatment for opioid dependence readily available in office-based settings, buprenorphine may facilitate a historic shift in addiction treatment from treatment facilities to general medical practices. Although many patients have benefited from the availability of buprenorphine in the United States, almost half of current prescribers are addiction specialists suggesting that buprenorphine treatment has not yet fully penetrated general practice settings. We examined factors affecting willingness to offer buprenorphine treatment among physicians with different levels of prescribing experience. Based on their prescribing practices, physicians were classified as experienced, novice, or as a nonprescriber and asked to assess the extent to which a list of factors impacted their prescription of buprenorphine. Several factors affected willingness to prescribe buprenorphine for all physicians: staff training; access to counseling and alternate treatment; visit time; buprenorphine availability; and pain medications concerns. Compared with other physicians, experienced prescribers were less concerned about induction logistics and access to expert consultation, clinical guidelines, and mental health services. They were more concerned with reimbursement. These data provide important insight into physician concerns about buprenorphine and have implications for practice, education, and policy change that may effectively support widespread adoption of buprenorphine.

KW - Buprenorphine

KW - HIV

KW - Opioid-related disorders

KW - Physician's practice patterns

KW - Willingness

UR - http://www.scopus.com/inward/record.url?scp=61349160477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349160477&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2008.06.006

DO - 10.1016/j.jsat.2008.06.006

M3 - Article

C2 - 18715741

AN - SCOPUS:61349160477

VL - 36

SP - 244

EP - 251

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 3

ER -